Upload
-
View
40
Download
1
Embed Size (px)
Citation preview
Product CatalogueProduct CatalogueIVD Industry
POCT Leading Brand
TUVRheinlandR
R
Getein Biotech, Inc. founded in March 2002, headquartered in
Nanjing, is a modern high-tech biotechnology company
specialized in developing, manufacturing and marketing in-
vitro diagnostic reagents and medical devices.
Getein achieved the Rheinland TÜV ISO 13485:2012 quality
management system cert i f icat ion and CE cert i f icat ion
sequentially, which ensure the quality, reliability and stability.
Until now, Getein has three product lines to assist disease
detection, monitoring and management, they are point-of-
care, clinical chemistry and raw material. Our R&D team is
devoted to providing you with more accurate and reliable
products, expanding our products portfolio.
ompany profile
2002Founded
762Employees
2000 GMP Workshop
246Researchers
Getein was Founded Founded in Nanjing, 17000 square meters of Getein’s total construction
area and 2,000 square meters GMP workshop.
Team ConstructionFocused on the rapid diagnosis scientific research.
Established a professional R&D team.
Domestic SalesCardiac test kits became available.
Occupied the domestic market.
ISO Certification and CE MarkAchieved the Rheinland TÜV ISO 13485:2012 quality management
system certification and CE certification.
Overseas SalesStarted the POCT business in Asia, the Middle East, Africa, lndia and etc.
Expand product lines: POCT, clinical chemistry and raw material.
Expand the market15000 domestic hospital users.
More than 1000 distributors and 50 strategic partners.
Pursue Excellence/Deliver Health Getein aims to become the world leading enterprise and is committed to
delivering health for global population.
C
GeteinHistory
2002
2003-2007
2008-2010
2011
2012-2013
2014-2015
Future
hs-CRP
PCT
D-Dimer
cTnI
NT-proBNP
CK-MB/cTnI/Myo
NT-proBNP/cTnI
PCT/CRP
CK-MB
CK-MB/cTnI
H-FABP
CK-MB/cTnI/H-FABP
NGAL
mAlb
CysC
HbA1c (Diabetes)
HCG (Fertility)
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
Product List
Application Departments
01
Getein IntroductionProduct List
Getein1600 Immunofluorescence Quantitative Analyzer
FIA8000 Quantitative Analyzer
Getein1100 Immunofluorescence Quantitative Analyzer
Partners/Exhibitions Certificates
01
02
04
06
08
10
CatalogueCatalogue
Gynecology Dept.
Gastroenterology Dept.
Respiratory Dept.
Urology Dept.
Getein’s products can be widely applied to many clinical departments as follows:Cardiology Dept.
Emergency Dept.
Oncology Dept.
Pediatrics Dept.
Clinical Laboratory
ICU
Nephrology Dept.
Endocrinology Dept.
Qualitative Products
√
√
√
√
√
√
√
√
FIA8000Getein1600 Getein1100 Qualitative Products
09 Controls
Getein1600 Parameters
Performance CharacteristicsFully automated
10.4 inch LCD touch screen
Automatic item test&result print
Routine and emergency mode
cTnI
NT-proBNP
Myocardial infarction
Cardiovascular inflammatory
diseases;Inflammatory
disorders
Venous thromboembolism;
Pulmonary embolism
0.1~50.0ng/ml
100~35000pg/ml
PCT
Disease Measuring Range
Heart failure
D-Dimer 0.1~10.0mg/L
0.5~200.0mg/Lhs-CRP
Reaction Time15min
10min
15min
SampleCat.#
IF 1001
IF 1002
IF 1003
IF 1005
IF 1006
IF 1007
Cut-offValue
S/P/W.B/
Fingertip Blood
0.1ng/ml
300pg/ml
3mg/L
10mg/L
S/P/W.B
S/P/W.B
3min
2.5~80.0ng/ml0.1~50.0ng/ml30~600ng/ml
CK-MB/cTnI/Myo
Myocardial injury 15minS/P/W.B
5ng/ml0.1ng/ml70ng/ml
10min0.5mg/L
0.1ng/mlS/P/W.B
P/W.B
0.1~50ng/mlSepsis; Septic shock
Getein1600Immunouorescence Quantitative Analyzer
H-FABP
D-Dimer
hs-CRP PCT
HCG
β2 - MG mAlb CysC
Test Items
Up to 48 samples per run
Maximum 150 tests per hour
Minimum 10 l sample volume
PC/LIS/HIS connectivity
0302
CARDIAC
VENOUS THROMBOEMBOLISM
INFLAMMATION MONITORING
FERTILITY
RENAL FUNCTION NGAL
NT-proBNP/cTnI NT-proBNP cTnI CK-MB/cTnI/Myo
CK-MB/cTnI/H-FABP
Test Item
IF 1004NT-proBNP
/cTnI
100-15000pg/ml
0.1-50ng/mlS/P/W.B
300pg/mL
0.1ng/ml 15minHeart failure;
Acute coronary syndrome
CysC
Early diagnosis of kidney disease;
Detection of kidney damage for
surgery patients0.5~10.0mg/L S/P/W.B 0.51~1.09
mg/L3minIF 1008
IF 1010 NGAL The best indicator of early renal injury 50~1500ng/ml Urine 135ng/ml 3min
IF 1011 β 2-MGKidney damage for
diabetic& hypertensive
patients0.5~20.0mg/L S/P/W.B 0.8~3.0
mg/L 3min
IF 1013
IF 1017
HCG
HbA1c
Pregnancy early test
Diabetes mellitus
25~10000mIU/ml
2%~14%
S/P
W.B
25mIU/ml
3.8%~5.8%
10min
5min
Micro Printer
cTnI
NT-proBNP
Myocardial infarction
Cardiovascular inflammatory
diseases;Inflammatory
disorders
Venous thromboembolism;
Pulmonary embolism
0.5~50.0ng/ml
100~35000pg/ml
PCT
Heart failure
D-Dimer 0.1~10.0mg/L
0.5~200.0mg/Lhs-CRP
15min
15min
15min
CG 1002
CG 1003
CG 1005
CG 1006
CG 1007
S/P/W.B/fingertip blood
0.5ng/ml
300pg/ml
3mg/L10mg/L
S/P/W.B
S/P/W.B
90s
2.5~80.0ng/ml0.5~50.0ng/ml30~600ng/ml
CK-MB/cTnI/Myo
Myocardial injury 15minS/P/W.B
5ng/ml0.5ng/ml70ng/ml
7min0.5mg/L
0.1ng/mLS/P/W.B
P/W.B
0.1~50ng/mlSepsis; Septic shock
CG 1009
CG 1010
CG 1011
CG 1013
CG 1017
CysC
mAlb
NGAL
β 2-MG
HCG
HbA1c
Early diagnosis of kidney disease;
Detection of kidney damage for
surgery patients
Early diagnosis and evaluation
of diabetic nephropathy
The best indicator of early renal injury
Kidney damage for diabetic
& hypertensive patients
Pregnancy early test
Diabetes mellitus
0.5~10.0mg/L
10~200mg/L
50~1500ng/ml
0.5~20.0mg/L
25~10000mIU/ml
2%~14%
S/P/W.B
Urine
Urine
S/P/W.B
S
W.B
0.51~1.09mg/L
20mg/ml
135ng/ml
0.8~3.0mg/L
25mIU/ml
3.8%~5.8%
3min
3min
3min
3min
10min
10min
CG 1008
CG 1004 NT-proBNP
/cTnI
Heart failure; Acute coronary
syndrome
100~12000pg/ml
0.5~50ng/mlS/P/W.B
300pg/mL
0.5ng/ml18min
CG 1001
FIA8000Quantitative Immunoassay Analyzer
User friendly
Small and light
Touch screen
Automatic barcode identification&result print
Performance Characteristics
FIA8000 Parameters
Touch Screen
Keypad
SD Card Slot
Power Switch&Connection Port
Test Card Slot
Comprehensive POCT markers available
Result available in 3~5s
Accurate in detection results
PC/LIS/HIS connectivity
0504
Disease Measuring Range
Reaction TimeSampleCat.# Cut-off
ValueTest Item
Test Cards
CG 1018 CK-MB 2.5~80.0ng/mlMyocardial injury 15minS/P/W.B 5ng/ml
CG 1012CK-MB/cTnI
Myocardial injury 15minS/P/W.B5ng/ml
0.5ng/ml
2.5~80.0ng/ml0.5~50.0ng/ml
cTnI
NT-proBNP
Myocardial infarction
Cardiovascular inflammatory
diseases;Inflammatory
disorders
Venous thromboembolism;
Pulmonary embolism
0.1~50.0ng/ml
100~35000pg/ml
PCT
Heart failure
D-Dimer 0.1~10.0mg/L
0.5~200.0mg/Lhs-CRP
15min
10min
15min
IF 1001
IF 1002
IF 1003
IF 1005
IF 1006
IF 1007
S/P/W.B/fingertip blood
0.1ng/ml
300pg/ml
3mg/L10mg/L
S/P/W.B
S/P/W.B
3min
2.5~80.0ng/ml0.1~50.0ng/ml30~600ng/ml
CK-MB/cTnI/Myo
Myocardial injury 15minS/P/W.B
5ng/ml0.1ng/ml
70ng/ml
10min0.5mg/L
0.1ng/mLS/P/W.B
P/W.B
0.1~50ng/mlSepsis; Septic shock
IF 1009
IF 1010
IF 1011
IF 1013
IF 1017
CysC
mAlb
NGAL
β 2-MG
HCG
HbA1c
Early diagnosis of kidney disease;
Detection of kidney damage for
surgery patients
Early diagnosis and evaluation
of diabetic nephropathy
The best indicator of early renal injury
Kidney damage for diabetic
& hypertensive patients
Pregnancy early test
Diabetes mellitus
0.5~10.0mg/L
10~200mg/L
50~1500ng/ml
0.5~20.0mg/L
25~10000mIU/ml
2%~14%
S/P/W.B
Urine
Urine
S/P/W.B
S/P
W.B
0.51~1.09mg/L
20mg/ml
135ng/ml
0.8~3.0mg/L
25mIU/ml
3.8%~5.8%
3min
3min
3min
3min
10min
5min
IF 1008
IF 1004 NT-proBNP
/cTnI
100-15000pg/ml
0.1-50ng/mlS/P/W.B
300pg/mL
0.1ng/ml 15minHeart failure;
Acute coronary syndrome
New technology Immunofluorescence Assay
Portability Small in size and light in weight
Suitable for use in various occasion
Ease of use Print results automatically
User friendly
Easy to operate
Multifunction Wide broad spectral of detection
High specificity and high sensitivity
Connectivity PC/LIS/HIS connectivity
Getein1100Immunouorescence Quantitative Analyzer
Performance Characteristics
Getein1100 Parameters
0706
Disease Measuring Range
Reaction TimeSampleCat.# Cut-off
ValueTest Item
Test Cards
IF 1012 CK-MB
/cTnIMyocardial injury
2.5~80.0ng/ml0.1~50.0ng/ml
15minS/P/W.B5ng/ml
0.1ng/ml
Qualitative Products
0908
Test Items/Test Cards Quality control (QC) is a procedure
or set of procedures intended to
ensure that a manufactured product
or performed service adheres to a
defined set of quality criteria or
meets the requirements of the client
or customer.
Controls
Product Name Levels Storage Format
QC 001
QC 002
QC 003
QC 004
QC 005
QC 006
QC 007
QC 008
QC 009
QC 010
QC 011
QC 012
Troponin I Control
CK-MB Control
MYO Control
PCT Control
hs-CRP Control
D-Dimer Control
NT-proBNP Control
Cystatin C Control
β 2-MG Control
NGAL Control
mAlb Control
H-FABP Control
1, 2 and 3
1, 2 and 3
1, 2 and 3
1, 2 and 3
1, 2 and 3
1, 2 and 3
1, 2 and 3
1, 2 and 3
1, 2 and 3
1, 2 and 3
1, 2 and 3
1, 2 and 3
Dry Powder
Dry Powder
Dry Powder
Dry Powder
Dry Powder
Dry Powder
Dry Powder
Dry Powder
Dry Powder
Dry Powder
Dry Powder
Dry Powder
Specications
CK-MB
hs-CRP
NT-proBNP
cTnI
CK-MB/cTnI/Myo
PCT
C
T
ID
S
CK-M
B/cTnI/Myo
C
T
ID
S
CK-M
B
C
T
ID
S
NT-p
roBNP
C
T
ID
S
PCT
C
T
ID
S
hs-C
RP
C
T
ID
S
cTnI
Standard Colorimetric Cards
Cat.#
Asia
Nanjing
Europe
Africa
North America
South America
Venezuela Chile Peru
Dominica Canda
France GermanyAustria Britain
HungaryLithuania
LatviaGreeceNorway
AsiaVietnam
ParkistanUAE
UzbekistanBangladesh
IranPhilippines
Saudi ArabiaJordanKorea
libyaBotswana
Zambia Egypt
MozambiqueGhanaNigeria
Partners
Exhibitions
10
7.MEDICAL FAIR ASIA
4.MEDICAL FAIR THAILAND
5.West African Health 8.FIME
2.AFRICA HEALTH1.ARAB HEALTH(Dubai)
6.MEDIC WEST AFRICA
3.MEDICA
12.AACC
CMEF China Intermational
Medical Equipment Fair
9.CMEF
EURASIA
10.Hospitalar 11.expo MED
Certificates
...
...
...
...
CerticatesCerticates
*OEM/ODM service for all products are availble.